TELO TELOMIR PHARMA

$1.09

TELOMIR PHARMA (TELO) is expected to report earnings on November 12, 2026, before the market open.

TELOMIR PHARMA Reported Earnings
Thursday, August 13, 2026 · 12:00 AM ET
Earnings Date
Nov 12
Thursday · Before Open
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP -

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About TELOMIR PHARMA

Telomir Pharmaceuticals Inc. is a pre-clinical-stage pharmaceutical company focused on the development and commercialization of TELOMIR-1, a novel small molecule being developed to function as an oral in situ therapeutic treatment for human stem cells. Telomir Pharmaceuticals Inc. is based in BALTIMORE.